Regulation of RAGE splicing by hnRNP A1 and Tra2β-1 and its potential role in AD pathogenesis

Journal of Neurochemistry

Volumn 133, Issue 2, 2015, Pages 187-198

  Liu, Xiao Yan ^a   Li, Hong Lei ^b   Su, Jia Bin ^a   Ding, Fei Hong ^a   Zhao, Jing Jing ^a   Chai, Fang ^a   Li, Yuan Xin ^a   Cui, Shi Cao ^a   Sun, Feng Yan ^a   Wu, Zhi Ying ^b,c   Xu, Ping ^a   Chen, Xian Hua ^a  

^a FUDAN UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

alternative splicing; Alzheimer's disease (AD); hnRNP A1; receptor for advanced glycation end products; Transformer2 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GLUCOSE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; MESSENGER RNA; REGULATOR PROTEIN; TRANSFORMER2BETA1 PROTEIN; UNCLASSIFIED DRUG; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; HNRNP A1; IMMUNOGLOBULIN RECEPTOR; NERVE PROTEIN; RNA BINDING PROTEIN; TRA2B PROTEIN, HUMAN;

AGED; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; MALE; MOLECULAR MECHANICS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; UPREGULATION; BIOLOGICAL MODEL; BRAIN; CELL CULTURE; DEFICIENCY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MONONUCLEAR CELL; NEUROBLASTOMA; PATHOLOGY; SPLICEOSOME; TUMOR CELL LINE;

AGED; ALZHEIMER DISEASE; BRAIN; CELL LINE, TUMOR; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEUROBLASTOMA; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; RNA-BINDING PROTEINS; SPLICEOSOMES; TRANSFECTION;

EID: 84926677550     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13069     Document Type: Article

References (48)

1. Ascolani A., Balestrieri E., Minutolo A., Mosti S., Spalletta G., Bramanti P., Mastino A., Caltagirone C., and, Macchi B., (2012) Dysregulated NF-κB Pathway in Peripheral Mononuclear Cells of Alzheimer's Disease Patients. Curr. Alzheimer Res. 9, 128-137.
2. Bhat N. R., (2010) Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators. J. Neurochem. 115, 551-562.
3. Bourgeois C. F., Lejeune F., and, Stévenin J., (2004) Broad Specificity of SR (Serine/Arginine) Proteins in the Regulation of Alternative Splicing of Pre-Messenger RNA. Prog. Nucleic Acid Res. Mol. Biol. 78, 37-88.
4. Burstein A. H., Grimes I., Galasko D. R., Aisen P. S., Sabbagh M., and, Mjalli A. M., (2014) Effect of TTP488 in patients with mild to moderate Alzheimer's disease. BMC Neurol. 14, 12.
5. Busch A., and, Hertel K. J., (2012) Evolution of SR protein and hnRNP splicing regulatory factors. Wiley Interdiscip. Rev. RNA. 3, 1-12.
6. Chen M., and, Manley J. L., (2009) Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol. 10, 741-754.
7. Corbo C., Orru S., and, Salvatore F., (2013) SRp20: an overview of its role in human diseases. Biochem. Biophys. Res. Commun. 436, 1-5.
8. Craft S., and, Stennis Watson G., (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 3, 169-178.
9. Cunnane S., Nugent S., Roy M., et al,. (2011) Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition 27, 3-20.
10. De Leon M., Ferris S., George A., et al,. (1983) Positron emission tomographic studies of aging and Alzheimer disease. Am. J. Neuroradiol. 4, 568-571.
11. Deane R. J., (2012) Is RAGE still a therapeutic target for Alzheimer's disease? Future Med. Chem. 4, 915-925.
12. Du Yan S., Chen X., Fu J., et al,. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
13. Glenner G. G., and, Wong C. W., (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
14. Guo Y., Zhao J., Bi J., Wu Q., Wang X., and, Lai Q., (2012) Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis. J. Hematol. Oncol. 5, 37.
15. Hanamura A., Cáceres J. F., Mayeda A., Franza B., and, Krainer A. R., (1998) Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4, 430-444.
16. Hardy J., and, Selkoe D. J., (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
17. Hoyer S., (2004) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur. J. Pharmacol. 490, 115-125.
18. Hudson B. I., Carter A. M., Harja E., Kalea A. Z., Arriero M., Yang H., Grant P. J., and, Schmidt A. M., (2008) Identification, classification, and expression of RAGE gene splice variants. FASEB J. 22, 1572-1580.
19. Jeynes B., and, Provias J., (2008) Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis. Curr. Alzheimer Res. 5, 432-437.
20. Kamide T., Kitao Y., Takeichi T., et al,. (2012) RAGE mediates vascular injury and inflammation after global cerebral ischemia. Neurochem. Int. 60, 220-228.
21. Kashima T., and, Manley J. L., (2003) A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat. Genet. 34, 460-463.
22. Koyama H., Yamamoto H., and, Nishizawa Y., (2007) RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases. Mol. Med. 13, 625-635.
23. Li S. J., Li Y., Cui S. C., Qi Y., Zhao J. J., Liu X. Y., Xu P., and, Chen X. H., (2013a) Splicing factor transformer-2beta (Tra2beta) regulates the expression of regulator of G protein signaling 4 (RGS4) gene and is induced by morphine. PLoS ONE 8, e72220.
24. Li S. J., Qi Y., Zhao J. J., Li Y., Liu X. Y., Chen X. H., and, Xu P., (2013b) Characterization of nuclear localization signals (NLSs) and function of NLSs and phosphorylation of serine residues in subcellular and subnuclear localization of transformer-2beta (Tra2beta). J. Biol. Chem. 288, 8898-8909.
25. Liu Y., Liu F., Grundke-Iqbal I., Iqbal K., and, Gong C. X., (2009) Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease. J. Neurochem. 111, 242-249.
26. Logsdon C. D., Fuentes M. K., Huang E. H., and, Arumugam T., (2007) RAGE and RAGE ligands in cancer. Curr. Mol. Med. 7, 777-789.
27. Lue L. F., Walker D. G., Brachova L., Beach T. G., Rogers J., Schmidt A. M., Stern D. M., and, Yan S. D., (2001) Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp. Neurol. 171, 29-45.
28. Mayeda A., Helfman D. M., and, Krainer A. R., (1993) Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol. Cell. Biol. 13, 2993-3001.
29. Meneghini V., Bortolotto V., Francese M. T., Dellarole A., Carraro L., Terzieva S., and, Grilli M., (2013) High-mobility group box-1 protein and β-amyloid oligomers promote neuronal differentiation of adult hippocampal neural progenitors via receptor for advanced glycation end products/nuclear factor-κB axis: relevance for Alzheimer's disease. J. Neurosci. 33, 6047-6059.
30. Mizukami K., Ishikawa M., Iwakiri M., Ikonomovic M. D., Dekosky S. T., Kamma H., and, Asada T., (2005) Immunohistochemical study of the hnRNP A2 and B1 in the hippocampal formations of brains with Alzheimer's disease. Neurosci. Lett. 386, 111-115.
31. Nasim M. T., Chernova T. K., Chowdhury H. M., Yue B.-G., and, Eperon I. C., (2003) HnRNP G and Tra2β: opposite effects on splicing matched by antagonism in RNA binding. Hum. Mol. Genet. 12, 1337-1348.
32. Nozaki I., Watanabe T., Kawaguchi M., et al,. (2007) Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains. Arch. Histol. Cytol. 70, 279-290.
33. O'Connor T., Sadleir K. R., Maus E., et al,. (2008) Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 60, 988-1009.
34. Ohe K., Watanabe T., Harada S., Munesue S., Yamamoto Y., Yonekura H., and, Yamamoto H., (2010) Regulation of alternative splicing of the receptor for advanced glycation endproducts (RAGE) through G-rich cis-elements and heterogenous nuclear ribonucleoprotein H. J. Biochem. 147, 651-659.
35. Rapoport S. I., (1999) In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci. 249, S46-S55.
36. Raucci A., Cugusi S., Antonelli A., Barabino S. M., Monti L., Bierhaus A., Reiss K., Saftig P., and, Bianchi M. E., (2008) A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 22, 3716-3727.
37. Said N., Rieder R., Hurwitz R., Deckert J., Urlaub H., and, Vogel J., (2009) In vivo expression and purification of aptamer-tagged small RNA regulators. Nucleic Acids Res. 37, e133.
38. Sakurai S., (2003) The AGE-RAGE System and Diabetic Nephropathy. J. Am. Soc. Nephrol. 14, S259-S263.
39. Serini S., Bizzarro A., Piccioni E., Fasano E., Rossi C., Lauria A., RM Cittadini A., Masullo C., and, Calviello G., (2012) EPA and DHA differentially affect in vitro inflammatory cytokine release by peripheral blood mononuclear cells from Alzheimer's patients. Curr. Alzheimer Res., 9, 913-923.
40. Son S. M., Jung E. S., Shin H. J., Byun J., and, Mook-Jung I., (2012) Abeta-induced formation of autophagosomes is mediated by RAGE-CaMKKbeta-AMPK signaling. Neurobiol. Aging 33, 1006, e1011-e1023.
41. Taylor R. P., Parker G. J., Hazel M. W., Soesanto Y., Fuller W., Yazzie M. J., and, McClain D. A., (2008) Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked N-acetylglucosaminyltransferase. J. Biol. Chem. 283, 6050-6057.
42. Venables J. P., Bourgeois C. F., Dalgliesh C., Kister L., Stevenin J., and, Elliott D. J., (2005) Up-regulation of the ubiquitous alternative splicing factor Tra2beta causes inclusion of a germ cell-specific exon. Hum. Mol. Genet. 14, 2289-2303.
43. Villa C., Ridolfi E., Fenoglio C., et al,. (2013) Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease. J. Alzheimer's Dis. 35, 487-494.
44. Wang Z. H., Li S. J., Qi Y., Zhao J. J., Liu X. Y., Han Y., Xu P., and, Chen X. H., (2011) HuD regulates the cpg15 expression via the 3'-UTR and AU-rich element. Neurochem. Res. 36, 1027-1036.
45. Wolf H., Jelic V., Gertz H. J., Nordberg A., Julin P., and, Wahlund L. O., (2003) A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol. Scand. Suppl. 179, 52-76.
46. Xie J., Mendez J. D., Mendez-Valenzuela V., and, Aguilar-Hernandez M. M., (2013) Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell. Signal. 25, 2185-2197.
47. Zahler A. M., Damgaard C. K., Kjems J., and, Caputi M., (2004) SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing. J. Biol. Chem. 279, 10077-10084.
48. Zhang W., Wang L. Z., Yu J. T., Chi Z. F., and, Tan L., (2012) Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease. J. Neurol. Sci. 315, 67-71.